S. Reed - May 21, 2025 Form 4 Insider Report for Evoke Pharma Inc (EVOK)

Role
Director
Signature
/s/ Matthew J. D'Onofrio, Attorney-in-fact for Vicke S. Reed
Stock symbol
EVOK
Transactions as of
May 21, 2025
Transactions value $
$0
Form type
4
Date filed
5/22/2025, 05:00 PM
Previous filing
Jan 29, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
REED VICKIE S Director C/O EVOKE PHARMA, INC., 420 STEVENS AVENUE, SUITE 230, SOLANA BEACH /s/ Matthew J. D'Onofrio, Attorney-in-fact for Vicke S. Reed 2025-05-22 0001405637

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVOK Stock Option (Right to Buy) Award $0 +1.25K +17.65% $0.00 8.33K May 21, 2025 Common Stock 1.25K $3.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The total number of shares of common stock subject to the option vests on the one-year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.